E-cadherin, a transmembrane glycoprotein essential for cell-cell adhesion, is often downregulated in LSCC, correlating with poorer tumor differentiation, increased risk of nodal metastasis, and advanced tumor stage; reduced expression may also be linked to shorter disease-free survival [125,126,127,185]. Here, CDH1 is linked to neoplasm.